Procurement of a seahorse bioscience, INC. XFE96 extracellular flux metabolic analyzer system

Ended Purchase Order Awarded Last action

Contract number
HHSN261201500215P
Awardee
Awarding agency
Obligated
$175,024

Award facts

Opportunity
Contract value 100% obligated
$175,024.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to Seahorse Bioscience, Inc. for the procurement of a Seahorse Bioscience, Inc. XFE96 Extracellular Flux Metabolic Analyzer System. The total ceiling value of the contract is $175,024.00. The contract has an ultimate completion date of June 29, 2016 and was awarded on June 30, 2015. The contract is not associated with a set-aside designation.

Quick answers

Who was awarded contract HHSN261201500215P?

HHSN261201500215P was awarded to Seahorse Bioscience, Inc. by National Cancer Institute (National Institutes of Health) on June 30, 2015.

How much is contract HHSN261201500215P worth?

The government has obligated $175,024 on HHSN261201500215P.

Was contract HHSN261201500215P competed?

The extent of competition for HHSN261201500215P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award